Genmab | GEN - Los Ingresos Por Intereses





Los Ingresos Por Intereses Cambio Fecha
Agios Pharmaceuticals USD 10.8M 1.62M 2026-03
Almirall EUR 2.71M 580K 2025-12
Amarin USD 3.37M 3.37M 2024-12
argenx SE USD 44M 874K 2026-03
AstraZeneca USD 80M 7M 2026-06
Bayer EUR 169M 39M 2025-12
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Exelixis USD 14.21M 1.92M 2026-06
Fresenius Medical Care EUR 14.7M 77K 2026-06
Genmab DKK 14M 11M 2026-03
GlaxoSmithKline GBP 22M 96M 2026-03
GN Store Nord DKK 99M 251M 2026-03
GRIFOLS EUR 9.56M 4.5M 2025-06
Hikma Pharmaceutical USD 4M 0 2024-12
Insmed USD 765K 55K 2024-09
Lakefront Biotherapeutics EUR 13.56M 991K 2026-03
Merck EUR 36M 15M 2026-03
Regeneron Pharmaceuticals USD 183.3M 200K 2026-06
Sanofi EUR 77M 17M 2026-06